# Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies

> **NCT05419180** · PHASE4 · COMPLETED · sponsor: **Biocodex** · enrollment: 52 (actual)

## Conditions studied

- Pharmacoresistant Focal Epilepsies

## Interventions

- **DRUG:** Stiripentol

## Key facts

- **NCT ID:** NCT05419180
- **Lead sponsor:** Biocodex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-13
- **Primary completion:** 2024-06-13
- **Final completion:** 2024-06-13
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05419180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05419180, "Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05419180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*